231 related articles for article (PubMed ID: 6092480)
21. The 2.2 A crystal structure of human chymase in complex with succinyl-Ala-Ala-Pro-Phe-chloromethylketone: structural explanation for its dipeptidyl carboxypeptidase specificity.
Pereira PJ; Wang ZM; Rubin H; Huber R; Bode W; Schechter NM; Strobl S
J Mol Biol; 1999 Feb; 286(1):163-73. PubMed ID: 9931257
[TBL] [Abstract][Full Text] [Related]
22. Purification and characterization of dog mastocytoma chymase: identification of an octapeptide conserved in chymotryptic leukocyte proteinases.
Caughey GH; Viro NF; Lazarus SC; Nadel JA
Biochim Biophys Acta; 1988 Jan; 952(2):142-9. PubMed ID: 3122835
[TBL] [Abstract][Full Text] [Related]
23. Squamous cell carcinoma antigen 2 is a novel serpin that inhibits the chymotrypsin-like proteinases cathepsin G and mast cell chymase.
Schick C; Kamachi Y; Bartuski AJ; Cataltepe S; Schechter NM; Pemberton PA; Silverman GA
J Biol Chem; 1997 Jan; 272(3):1849-55. PubMed ID: 8999871
[TBL] [Abstract][Full Text] [Related]
24. Identification of a human neutrophil angiotension II-generating protease as cathepsin G.
Tonnesen MG; Klempner MS; Austen KF; Wintroub BU
J Clin Invest; 1982 Jan; 69(1):25-30. PubMed ID: 6172448
[TBL] [Abstract][Full Text] [Related]
25. Albumin is a substrate of human chymase. Prediction by combinatorial peptide screening and development of a selective inhibitor based on the albumin cleavage site.
Raymond WW; Ruggles SW; Craik CS; Caughey GH
J Biol Chem; 2003 Sep; 278(36):34517-24. PubMed ID: 12815038
[TBL] [Abstract][Full Text] [Related]
26. Chemistry of a human monocyte-derived cell line (U937): identification of the angiotensin I-converting activity as leukocyte cathepsin G.
Snyder RA; Kaempfer CE; Wintroub BU
Blood; 1985 Jan; 65(1):176-82. PubMed ID: 2981131
[TBL] [Abstract][Full Text] [Related]
27. Extended Cleavage Specificity of the Rat Vascular Chymase, a Potential Blood Pressure Regulating Enzyme Expressed by Rat Vascular Smooth Muscle Cells.
Berglund P; Akula S; Fu Z; Thorpe M; Hellman L
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33198413
[TBL] [Abstract][Full Text] [Related]
28. Biosynthesis and physio-pharmacological actions of angiotensin peptides: 1. Synthetic enzymes.
Haulică I; Bild W; Rădăşanu O
Rev Med Chir Soc Med Nat Iasi; 2006; 110(1):167-72. PubMed ID: 19292099
[TBL] [Abstract][Full Text] [Related]
29. Extrarenal angiotensin-forming enzymes.
Genest J; Cantin M; Garcia R; Thibault G; Gutkowska J; Schiffrin E; Kuchel O; Hamet P
Clin Exp Hypertens A; 1983; 5(7-8):1065-80. PubMed ID: 6315265
[TBL] [Abstract][Full Text] [Related]
30. Active site mapping of the serine proteases human leukocyte elastase, cathepsin G, porcine pancreatic elastase, rat mast cell proteases I and II. Bovine chymotrypsin A alpha, and Staphylococcus aureus protease V-8 using tripeptide thiobenzyl ester substrates.
Harper JW; Cook RR; Roberts CJ; McLaughlin BJ; Powers JC
Biochemistry; 1984 Jun; 23(13):2995-3002. PubMed ID: 6380580
[TBL] [Abstract][Full Text] [Related]
31. ACE-versus chymase-dependent angiotensin II generation in human coronary arteries: a matter of efficiency?
Tom B; Garrelds IM; Scalbert E; Stegmann AP; Boomsma F; Saxena PR; Danser AH
Arterioscler Thromb Vasc Biol; 2003 Feb; 23(2):251-6. PubMed ID: 12588767
[TBL] [Abstract][Full Text] [Related]
32. Angiotensin generation in the brain and drinking: indications for the involvement of endopeptidase activity distinct from cathepsin D.
Tonnaer JA; Wiegant VM; De Jong W
Brain Res; 1981 Nov; 223(2):343-53. PubMed ID: 7025965
[TBL] [Abstract][Full Text] [Related]
33. Identification of serine proteinases with tonin-like activity in the rat submandibular and prostate glands.
Araujo GW; Pesquero JB; Lindsey CJ; Paiva AC; Pesquero JL
Biochim Biophys Acta; 1991 May; 1074(1):167-71. PubMed ID: 1646031
[TBL] [Abstract][Full Text] [Related]
34. Human skin chymotrypsin-like proteinase chymase. Subcellular localization to mast cell granules and interaction with heparin and other glycosaminoglycans.
Sayama S; Iozzo RV; Lazarus GS; Schechter NM
J Biol Chem; 1987 May; 262(14):6808-15. PubMed ID: 3553192
[TBL] [Abstract][Full Text] [Related]
35. Effects of angiotensin II generated by an angiotensin converting enzyme-independent pathway on left ventricular performance in the conscious baboon.
Hoit BD; Shao Y; Kinoshita A; Gabel M; Husain A; Walsh RA
J Clin Invest; 1995 Apr; 95(4):1519-27. PubMed ID: 7706457
[TBL] [Abstract][Full Text] [Related]
36. Potent inactivator of alpha-chymotrypsin: 2,2-dimethyl-3-(N-4-cyanobenzoyl)amino-5-phenyl pentanoic anhydride.
Ito K; Igarashi K; Muramatsu M; Harada T; Hayashi Y; Katada J; Uno I
Biochem Biophys Res Commun; 1997 Nov; 240(3):850-5. PubMed ID: 9398657
[TBL] [Abstract][Full Text] [Related]
37. Chymase: its pathophysiological roles and inhibitors.
Fukami H; Okunishi H; Miyazaki M
Curr Pharm Des; 1998 Dec; 4(6):439-53. PubMed ID: 10197055
[TBL] [Abstract][Full Text] [Related]
38. Angiotensin II generation by mast cell alpha- and beta-chymases.
Caughey GH; Raymond WW; Wolters PJ
Biochim Biophys Acta; 2000 Jul; 1480(1-2):245-57. PubMed ID: 10899625
[TBL] [Abstract][Full Text] [Related]
39. Alpha 2-macroglobulin capture allows detection of mast cell chymase in serum and creates a reservoir of angiotensin II-generating activity.
Raymond WW; Su S; Makarova A; Wilson TM; Carter MC; Metcalfe DD; Caughey GH
J Immunol; 2009 May; 182(9):5770-7. PubMed ID: 19380825
[TBL] [Abstract][Full Text] [Related]
40. Angiotensin II-forming activity in a reconstructed ancestral chymase.
Chandrasekharan UM; Sanker S; Glynias MJ; Karnik SS; Husain A
Science; 1996 Jan; 271(5248):502-5. PubMed ID: 8560264
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
